ML167
CAS No. 1285702-20-6
ML167 ( ML-167;ML 167 )
Catalog No. M11167 CAS No. 1285702-20-6
A potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | Get Quote |
|
5MG | 63 | Get Quote |
|
10MG | 105 | Get Quote |
|
25MG | 217 | Get Quote |
|
50MG | 371 | Get Quote |
|
100MG | 552 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML167
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
-
DescriptionA potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.
-
SynonymsML-167;ML 167
-
PathwayCell Cycle/DNA Damage
-
TargetCLK
-
RecptorCLK1;CLK2;CLK4;Dyrk1B
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1285702-20-6
-
Formula Weight335.36
-
Molecular FormulaC19H17N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 62 mg/mL (184.9 mM); Ethanol: 11 mg/mL (32.8 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESOCC1=CC=C(C2=CC3=C(NCC4=CC=C(C)O4)N=CN=C3C=C2)O1
-
Chemical Name5-[4-[[(5-Methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CLK inhibitor T3
CLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110nM for CLK1,2 and 3, respectively.
-
ML197
ML197 is a potent, selective small molecule inhibitor of Cdc2-like kinases (CLK) and DYRK with IC50 of 96/40/206 nM for CLK1/CLK4/Dyrk1A, respectively.
-
Leucettine L41
A novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively.